Revvity, Inc. (RVTY)
NYSE: RVTY · Real-Time Price · USD
89.88
-1.05 (-1.15%)
Aug 14, 2025, 12:01 PM - Market open
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2014 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 | Jan '21 Jan 3, 2021 | 2014 - 2019 |
| Discovery & Analytical Solutions Product Revenue (Pre-Q3 2022) | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Discovery & Analytical Solutions Product Revenue (Pre-Q3 2022) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Discovery & Analytical Solutions Service Revenue (Pre-Q3 2022) | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Discovery & Analytical Solutions Service Revenue (Pre-Q3 2022) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Diagnostics Revenue (Pre-Q3 2022) | 1.50B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Diagnostics Revenue (Pre-Q3 2022) Growth | 4.25% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostics Product Revenue (Pre-Q3 2022) | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostics Product Revenue (Pre-Q3 2022) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostics Service Revenue (Pre-Q3 2022) | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostics Service Revenue (Pre-Q3 2022) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Discovery & Analytical Solutions Revenue (Post-Q2 2022) | 1.25B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Discovery & Analytical Solutions Revenue (Post-Q2 2022) Growth | 2.36% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Product | 2.34B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Product Growth | -0.08% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Service | 416.82M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Service Growth | 24.78% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Life Sciences Revenue (Pre-Q3 2022) | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Life Sciences Revenue (Pre-Q3 2022) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Applied Markets Revenue (Pre-Q3 2022) | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Applied Markets Revenue (Pre-Q3 2022) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2014 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 | Jan '21 Jan 3, 2021 | 2014 - 2019 |
| Other | 36.59M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 137.41% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Discovery & Analytical Solutions Operating Income (Pre-Q3 2022) | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Discovery & Analytical Solutions Operating Income (Pre-Q3 2022) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 36.59M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 137.41% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostics Operating Income (Pre-Q3 2022) | 373.19M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostics Operating Income (Pre-Q3 2022) Growth | 10.02% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Discovery & Analytical Solutions Operating Income (Post-Q2 2022) | 448.02M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Discovery & Analytical Solutions Operating Income (Post-Q2 2022) Growth | 0.98% |
Log In |
Log In |
Log In |
Log In | Upgrade
|